Venoruton Intens, 20 pcs

Instructions for use for Venoruton Intens, 20 pcs

Important notes (compulsory information):

Venoruton Intens. Active substance: poly (0-2-hydroxyethyl) rutoside. Areas of application: For complaints in a row of leg vein diseases (chronic vein insufficiency): Treatment of leg swelling (edema) and relief in heavy, tired legs, stress feelings and tingling.

For risks and side effects, read the package leaflet and ask your doctor or pharmacist.


LEAFLET: INFORMATION FOR THE USER

Venoruton intens
500 mg film tablet
Poly (O -2-hydroxyethyl) rutoside

Read the entire leaflet carefully before starting using this medicine, because it contains important information. Always use this medicine as described in this leaflet or exactly as your doctor's or pharmacist instructions.

• Lift the package leaflet. You might want to read it again.
• Ask your pharmacist if you need more information or advice.
• If you notice side effects, contact your doctor or pharmacist. This also applies to side effects that are not indicated in this leaflet. See section 4.
• If you do not feel better, but even worse, contact your doctor.

What is in this packing admition

1. What is Venoruton intens and what is it used for?
2. What should you consider before taking Venoruton intens?
3. How is Venoruton to take intens?
4. WHAT SIDE EFFECTS ARE POSSIBLE?
5. How to keep Venoruton intens?
6. Content of the packing and further information.

1. What is Venoruton intens and what is it used for?

Venoruton Intens is a vein preparation. Due to the anti-edemate (Tissue-weathful) Effect of Venoruton Intens are edema (Leg swelling) reduced. Complaints such. B. heavy, tired legs and tension feelings as well as tingling in the legs are thus alleviated.

Field of use:
Application in complaints resulting from diseases of the leg vein (chronic vein insufficiency): treatment of leg swelling (edema) and relief in heavy, tired legs, tension feelings and tingling.

2. What should you pay attention to intens before taking Venoruton?

Venoruton Intens may not be taken,
If they are allergic to the active ingredient poly (0-2-hydroxyethyl) rutoside, yellow orange S, aluminum salt or one of the other ingredients of this medicine mentioned in section 6.

Warnings and Precautions:
Please talk to your doctor or pharmacist before you Venoruton Apply intens. Yellow orange S, aluminum salt can cause hypersensitivity reactions.

Taking Venoruton Intens together with other medicines:
Please inform your doctor or pharmacist if you take / use other medicines, recently taken / applied / applied or intended other medicines. Interactions with other medicines are not yet known. Venoruton Intens show no interaction with coagulant drugs of the Cumarin type.

Pregnancy and breast feeding period:
If you are pregnant or breastfeeding, or if you suspect to be pregnant or intend to become pregnant, ask your doctor or pharmacist for advice before applying this medicine.

Pregnancy:
Since only inadequate experiences in the first months of pregnancy are available, you should Venoruton Intensal in need of children and pregnancy only after consultation with their doctor.

Latving:
Please talk to your doctor about this. There are no investigations in humans to transition the active ingredient into breast milk. Traces of the active ingredient found at animal experiments in breast milkn, are not clinical significance and are therefore probably also harmless to the human infant.

Driving and ability to operate machines:
Venoruton Intens has no influence on the ability to drive and the ability to serve machines.

3. How to take Venoruton intens?

Always take this medicine exactly as described in this leaflet or just according to the consultation made with your doctor or pharmacist. Ask your doctor or pharmacist if you are not sure.

Dosage:
The recommended dose is 1 film tablet 2 times a day.

Type of application:
Please take the film-coated tablets during meals or immediately after that with a little fluid.

Note:
In this film tablet, the active ingredient is stored in a carrier scaffolding. In individual cases, it may happen that the carrier scaffold is not degraded in the intestine and therefore appears in the chair. However, the drug delivery from the film-coated tablets into the body was not affected.

Duration of application:
The duration of ingestion depends on the complaints. Basically there is no time limitation of the application time. When stopping the complaints, treatment can be continued for a longer period of time after medical consultation. The success depends essentially on the consistent compliance with the prescribed dosage and the duration of treatment.

If you have a larger amount of Venoruton Have taken intens than you should:
There are no poisoning cases with Venoruton Intens known, therefore no measures are required.

If you are taking Venoruton Forgot intens:
Do not take the double amount when you forget the previous taking.

If you are taking Venoruton Cancel intens:
Interrupt the treatment with Venoruton Intensity or terminate the taking prematurely, so you need to expect that the desired effect does not set up or the clinical picture deteriorates again. Please consult with your doctor if you want to end or interrupt the treatment. If you have further questions about taking this medicine, contact your doctor or pharmacist.

4. Which side effects are possible?

Like all medicines, this medicine can also have side effects, but they do not have to occur each other.

The frequency information on side effects is based on the following categories:
Very often:	more than 1 treated from 10
Frequently:	1 to 10 treated from 100
Occasionally:	1 to 10 treated from 1 000
Rarely:	1 to 10 treated from 10 000
Very rare:	less than 1 treated from 10 000
Not known:	Frequency on the basis of the available data does not estimate.

Possible side effects:
In very rare cases, slight side effects were reported (Allergic skin reactions, light gastrointestinal disorders, headaches, flush facial), which quickly decay after discontinuing the preparation. Yellow orange S, aluminum salt can cause hypersensitivity reactions.

Message of side effects:
If you notice side effects, contact your doctor or pharmacist. This also applies to side effects that are not indicated in this leaflet. You can also effectively effect the Federal Institute for Medicines and Medical Devices, Dept. Pharmacovigilance, Kurt-Georg-Kiesinger Allee 3, D-53175 Bonn, website: www.bfarm.de. By reporting side effects, you can help to provide more information about the security of this medicine.

5. How to keep Venoruton intens?

Keep this medicine Ffor children inaccessible. They may be this medicine after the on the carton or Blister stated expiry date no longer use.

Storage indication:
Store in the original packaging to protect the content from moisture.

6. Content of the pack and further information.

What Venoruton Intensity contains:
The active ingredient is poly (0-2-hydroxyethyl) rutoside.
1 film tablet contains 500 mg of poly (0-2-hydroxyethyl) rutoside.

The other ingredients are:
Polyacrylate dispersion 30%; Talc; Copovidone; Yellow orange S, aluminum salt; Magnesium stearate; Titanium dioxide; Macrogol 6000.

Like Venoruton Intens looks and content of the pack:
Orange, elongated film tablet with embossing. Original packs of 20 Film tablets, 50 film-coated tablets and 100 film-coated tablets

Pharmaceutical entrepreneur and manufacturer:
GlaxoSmithKline Consumer Healthcare GmbH & Co. KG
80258 Munich
Barthstraße 4
80339 Munich
Telephone (089) 78 77-209
Fax (089) 78 77-304
E-mail: [email protected]

This information information was last revised in June 2016.

Source: Information of the leaflet
Status: 04/2017